Do You Have Atrial Fibrillation?
Local physicians are conducting The CONVERGE Study, a clinical research opportunity for patients with Atrial Fibrillation. The purpose of the CONVERGE clinical trial is to establish the safety and efficacy of the Convergent Procedure, a “hybrid” approach that combines two AFib treatments into one therapy for persistent AFib patients.
You may qualify for the CONVERGE Study if:
The surgical and catheter procedure, and the devices used in this investigation will be billed to the patient’s health insurance.
- You are between 18 and 80 years of age
- You have experienced persistent AFib symptoms
- You have taken heart medications (antiarrhythmic drugs) that are not working
- You are willing and able to receive the study-related procedures and attend follow-up visits.
If you or someone you know has been diagnosed with Atrial Fibrillation, consider participating in the CONVERGE Study.
For more information please click Here.